Skip to main content

Advertisement

Log in

Provision of Contraceptive Services to Women with Diabetes Mellitus

  • Original Research
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

ABSTRACT

BACKGROUND

Women with diabetes mellitus who delay pregnancy until glycemic control is achieved experience lower rates of adverse pregnancy outcomes.

OBJECTIVE

To compare rates of provision of contraceptive services among women with diabetes mellitus and women without chronic medical conditions.

DESIGN

A retrospective cohort study of 459,181 women aged 15–44 who had continuous membership and pharmacy benefits in a managed care organization in Northern California between January 2006 and June 2007. Rates of documented provision of contraceptive counseling, prescriptions, and services were compared between women with diabetes and women without chronic medical conditions.

RESULTS

Among 8,182 women with diabetes and 122,921 women without any chronic conditions, women with diabetes were less likely than women without a chronic condition to have documented receipt of any contraceptive counseling, prescriptions, or services (47.8% vs 62.0%, p < 0.001). After controlling for age and race, women with diabetes were more likely to have undergone tubal sterilization compared to women without a chronic condition (OR = 1.41, 95% CI 1.30–1.54), but less likely to have received highly effective, reversible methods of contraception such as intrauterine contraception (OR = 0.68, 95% CI 0.61–0.75). In addition, more women with diabetes had undergone hysterectomy, which is rarely performed solely for contraceptive purposes.

CONCLUSIONS

Women with diabetes were less likely to receive highly effective reversible contraception and more likely to undergo sterilization procedures. Increasing the use of highly effective reversible contraceptives may help diabetic women who want to retain their fertility to delay pregnancy until glycemic control is achieved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kinsley B. Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus. Clin Ther. 2007;29(Suppl D):S153–60.

    Article  PubMed  CAS  Google Scholar 

  2. Willhoite MB, Bennert HW Jr, Palomaki GE, Zaremba MM, Herman WH, Williams JR, et al. The impact of preconception counseling on pregnancy outcomes. The experience of the Maine Diabetes in Pregnancy Program. Diabetes Care. 1993;16(2):450–5.

    Article  PubMed  CAS  Google Scholar 

  3. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health. 2006;38(2):90–6.

    Article  PubMed  Google Scholar 

  4. Schwarz EB, Maselli J, Gonzales R. Contraceptive counseling of diabetic women of reproductive age. Obstet Gynecol. 2006;107(5):1070–4.

    Article  PubMed  Google Scholar 

  5. Chuang CH, Chase GA, Bensyl DM, Weisman CS. Contraceptive use by diabetic and obese women. Womens Health Issues. 2005;15(4):167–73.

    Article  PubMed  Google Scholar 

  6. Cyganek K, Hebda-Szydlo A, Katra B, Skupien J, Klupa T, Janas I, et al. Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning. Diabetes Technol Ther. 2010;12(1):41–7.

    Article  PubMed  Google Scholar 

  7. Yang J, Cummings EA, O'Connell C, Jangaard K. Fetal and neonatal outcomes of diabetic pregnancies. Obstet Gynecol. 2006;108(3 Pt 1):644–50.

    Article  PubMed  Google Scholar 

  8. Centers for Disease Control and Prevention. Update on overall prevalence of major birth defects—Atlanta, Georgia, 1978–2005. MMWR Morb Mortal Wkly Rep. 2008;11(57(1)):1–5..

    Google Scholar 

  9. Johnson K, Posner SF, Biermann J, Cordero JF, Atrash HK, Parker CS, et al. Recommendations to improve preconception health and health care—United States. A report of the CDC/ATSDR Preconception Care Work Group and the Select Panel on Preconception Care. MMWR Recomm Rep. 2006;55(RR-6):1–23.

    PubMed  Google Scholar 

  10. Mahmud M, Mazza D. Preconception care of women with diabetes: a review of current guideline recommendations. BMC Womens Health. 2010;10:5.

    PubMed  Google Scholar 

  11. D'Angelo D, Williams L, Morrow B, Cox S, Harris N, Harrison L, et al. Preconception and interconception health status of women who recently gave birth to a live-born infant—Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 26 reporting areas, 2004. MMWR Surveill Summ. 2007;56(10):1–35.

    PubMed  Google Scholar 

  12. Kim C, Ferrara A, McEwen LN, Marrero DG, Gerzoff RB, Herman WH, et al. Preconception care in managed care: the translating research into action for diabetes study. Am J Obstet Gynecol. 2005;192(1):227–32.

    Article  PubMed  Google Scholar 

  13. Karter AJ, Ackerson LM, Darbinian JA, D'Agostino RB Jr, Ferrara A, Liu J, et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med. 2001;111(1):1–9.

    Article  PubMed  CAS  Google Scholar 

  14. World Health Organization. Medical Eligibility Criteria for Contraceptive Use [Book]. Geneva 2009. Available from: http://whqlibdoc.who.int/publications/2010/9789241563888_eng.pdf <accessed Aug 26, 2011>

  15. Liu L, Allison JE, Herrinton LJ. Validity of computerized diagnoses, procedures, and drugs for inflammatory bowel disease in a northern California managed care organization. Pharmacoepidemiol Drug Saf. 2009;18(11):1086–93.

    Article  PubMed  Google Scholar 

  16. Lawrence JM, Liu IL, Towner WJ. Trends and correlates of HIV testing during pregnancy in racially/ethnically diverse insured population, 1997–2006. Matern Child Health J. 2009;13(5):633–40.

    Article  PubMed  Google Scholar 

  17. Magid DJ, Shetterly SM, Margolis KL, Tavel HM, O'Connor PJ, Selby JV, et al. Comparative effectiveness of angiotensin-converting enzyme inhibitors versus beta-blockers as second-line therapy for hypertension. Circ Cardiovasc Qual Outcomes. 2010;3(5):453–8.

    Article  PubMed  Google Scholar 

  18. Steiner MJ, Dalebout S, Condon S, Dominik R, Trussell J. Understanding risk: a randomized controlled trial of communicating contraceptive effectiveness. Obstet Gynecol. 2003;102(4):709–17.

    Article  PubMed  Google Scholar 

  19. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, et al. Full accounting of diabetes and pre-diabetes in the US population in 1988–1994 and 2005–2006. Diabetes Care. 2009;32(2):287–94.

    Article  PubMed  Google Scholar 

  20. Allen VM, Armson BA, Wilson RD, Blight C, Gagnon A, Johnson JA, et al. Teratogenicity associated with pre-existing and gestational diabetes. J Obstet Gynaecol Can. 2007;29(11):927–44.

    Article  PubMed  Google Scholar 

  21. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005;115(3):e290-6.

    Article  PubMed  Google Scholar 

  22. Monea E, Thomas A. Unintended pregnancy and taxpayer spending. Perspect Sex Reprod Health. 2011;43(2):88–93.

    Article  PubMed  Google Scholar 

  23. Sonfield A, Kost K, Gold RB, Finer LB. The public costs of births resulting from unintended pregnancies: national and state-level estimates. Perspect Sex Reprod Health. 2011;43(2):94–102.

    Article  PubMed  Google Scholar 

  24. Curtis KM, Mohllajee AP, Peterson HB. Regret following female sterilization at a young age: a systematic review. Contraception. 2006;73(2):205–10.

    Article  PubMed  Google Scholar 

  25. Curtis KM, Jamieson DJ, Peterson HB, Marchbanks PA. Adaptation of the World Health Organization's medical eligibility criteria for contraceptive use for use in the United States. Contraception. 2010;82(1):3–9.

    Article  PubMed  Google Scholar 

  26. Lidegaard O, Lokkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ. 2009;339:b2890.

    Google Scholar 

  27. Hatcher R, Trussell J, Stewart F, Nelson A, Cates W, Guest F, et al. Contraceptive Technology. 18th ed. New York: Ardent Media; 2004.

    Google Scholar 

  28. Sivin I, el Mahgoub S, McCarthy T, Mishell DR Jr, Shoupe D, Alvarez F, et al. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study. Contraception. 1990;42(4):361–78.

    Article  PubMed  CAS  Google Scholar 

  29. Akers AY, Gold MA, Borrero S, Santucci A, Schwarz EB. Providers' perspectives on challenges to contraceptive counseling in primary care settings. J Womens Health (Larchmt). 2010;19(6):1163–70.

    Article  Google Scholar 

  30. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992;82(5):703–10.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements and Funding

Eleanor Bimla Schwarz participated in the study design, interpretation of results, and manuscript writing; her time was supported by NICHD K23 HD051585. Debbie Postlethwaite participated in the study design, supervision of data collection, interpretation of results, and manuscript writing. Yun-Yi Hung participated in study design, data collection, conducted analyses, interpretation of results, and manuscript editing. Mary Anne Armstrong participated in study design, provided biostatistical expertise, interpretation of results, and manuscript editing. Eric Lantzman participated in study design, data collection, manuscript editing, and contributed to the discussion. Michael A. Horberg participated in interpretation of results, manuscript editing, and contributed to the discussion.

Conflict of Interest

None disclosed.

Sources of Funding

Dr. Schwarz was supported by NICHD grant K23 HD051585. The Kaiser Foundation Research Institute (KFRI) administered research funding provided by Bayer HealthCare Pharmaceutical Inc. for the study conducted by the Division of Research, Kaiser Permanente Northern California.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eleanor Bimla Schwarz MD, MS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schwarz, E.B., Postlethwaite, D., Hung, YY. et al. Provision of Contraceptive Services to Women with Diabetes Mellitus. J GEN INTERN MED 27, 196–201 (2012). https://doi.org/10.1007/s11606-011-1875-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-011-1875-6

KEY WORDS

Navigation